DISTINGUISHED SPEAKERS Diana Chingos, Consultant; Chair, Cancer Survivorship Advisory Council; Committee Member, CISN; Kenneth T. Norris Comprehensive Cancer Center, USC; Investigational Drugs Steering Committee & Patient Advocate Steering Committee, NCI
Jim Chinitz, Chief Executive Officer, Population Diagnostics
Georges Dagher, Deputy Director, Clinical Research, INSERM
Denise Driscoll, Director, Laboratory Accreditation and Regulatory Affairs, College of American Pathologists
Ian Fore, Director, Biorepository and Pathology Informatics, Center for Bioinformatics, NCI, NIH
Berthold Huppertz, Professor, Cell Biology & Vice Chair, Histology and Embryology; Director and Chief Executive Officer,Institute of Cell Biology, Medical University of Graz Harrachgasse; Biobank Graz
Hartmut Juhl, Adjunct Professor; Chief Executive Officer, Georgetown University & University of Hamburg; Indivumed & Inostics
Liis Leitsalu- Moynihan, Translational Genomics Working Group, Estonian Genome Center, University of Tartu
Ashokkumar Patel, Bioinformatics PI, AIDS and Cancer Specimen Resource (ACSR), UCSF
Vinagolu Rajasekhar, Senior Research Scientist, Memorial Sloan-Kettering Cancer Centre New York
Zackery Riley, Manager, Tissue Procurement and Process Development, Allen Institute for Brain Science
Michael Roehrl, Assistant Professor, Pathology and Laboratory Medicine, Boston University
Charles Saller, President, Chief Executive Officer, ABS
Athanassios Sambanis, Professor, Chemical & Biomolecular Engineering, Georgia Institute of Technology
Petar Stojadinovic, President, Open Biobank
George Vasmatzis, Assistant Professor, Laboratory Medicine and Pathology, Mayo Medical School
|